The immuno-oncology framework: Enabling a new era of cancer therapy.
about
The Concept of Hormesis in Cancer Therapy - Is Less More?Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring.Comparative analysis of cancer vaccine settings for the selection of an effective protocol in miceEnhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Identification of differences in immunotherapy knowledge and practice patterns among oncologists from six European countries.Role of immunotherapy in castration-resistant prostate cancer (CRPC).Cancer immunotherapies, their safety and toxicity.Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario.Cancer Immunotherapy, Part 3: Challenges and Future Trends.End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma.The Safety of available immunotherapy for the treatment of glioblastoma.The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches.
P2860
Q26800519-FD0DDDE1-A6D9-44CB-A9F5-CC2A51688598Q34522294-77CA03D6-99A6-4382-AEEC-0FFC873C0A0FQ36859227-9C46B995-B4F4-4ECE-B983-E9BBCBCF0046Q37114367-117CA285-110A-43E6-9865-E4E7DC58A7D6Q37567788-F23067D0-5064-4CD2-B0CA-A67DE08D9650Q38104730-E690174B-7B14-4429-9FA9-92BB21226006Q38106230-49DCB961-1912-4662-A0B4-6BC78D4916F8Q38143201-2D976A57-6686-49AC-900B-8169DD606C36Q38646290-769083E3-D1E7-4FD2-B096-C01CDEBF822AQ38732370-B62FEC70-88ED-44AA-93FA-66C9599DBDAAQ39042442-FCE0AF17-72DC-40FF-8C14-9ECCC3A5305EQ39100049-D4ED5D76-13FB-4757-BF7F-F639F15D9841
P2860
The immuno-oncology framework: Enabling a new era of cancer therapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The immuno-oncology framework: Enabling a new era of cancer therapy.
@ast
The immuno-oncology framework: Enabling a new era of cancer therapy.
@en
The immuno-oncology framework: Enabling a new era of cancer therapy.
@nl
type
label
The immuno-oncology framework: Enabling a new era of cancer therapy.
@ast
The immuno-oncology framework: Enabling a new era of cancer therapy.
@en
The immuno-oncology framework: Enabling a new era of cancer therapy.
@nl
prefLabel
The immuno-oncology framework: Enabling a new era of cancer therapy.
@ast
The immuno-oncology framework: Enabling a new era of cancer therapy.
@en
The immuno-oncology framework: Enabling a new era of cancer therapy.
@nl
P2860
P356
P1433
P1476
The immuno-oncology framework: Enabling a new era of cancer therapy.
@en
P2093
Cedrik Britten
P2860
P304
P356
10.4161/ONCI.19268
P577
2012-05-01T00:00:00Z